Page 3 - Beyond Human News Today

Techland have announced how long Dying Light 2 will take to complete, the main story, the side quests, and the entire game.

Techland have announced that to fully complete all of Dying Light 2: Beyond Human you will need to spend over 500 hours playing the game.

“Be thankful for your enemies. Hardship makes us strong. Tyranny forces us to do what we thought we couldn’t do. I see a terrible, terrible conflict coming, but this is going to turn out really, really good” – G. Edward Griffin The 90th birthday celebration of the revered G. Edward Griffin, who has informed so many about the fraudulent nature of the Federal Reserve and our money system with his book “The Creature of Jekyll Island,” was the highlight of the Red Pill Expo in November i...

Legal Autonomous Weapons that use A.I. to kill targets with no human intervention are being regulated, but military-powered countries are refusing---the U.N. will have to intervene.

Elon Musk's Neuralink hopes to have the human trials for brain chips by 2022. (Photo : @bretkavanaugh / Unsplash) Elon Musk said Neuralink, a brain-interface technology company he co-founded, is hoping to start implanting its microchips in humans next year.

Noah Media Group has released a trailer (watch it below) for the 60-minute triathlon documentary Beyond Human. It’s producing the documentary for the Professional Triathletes Organisation (PTO). The film follows triathletes as they prepare for the PTO’s flagship event, The Collins Cup – a rivalry fuelled, Ryder Cup-style format. The aim is to bring out the excitement, rivalry, drama and personalities of the sport, to help attract a wider fan base. The documentary features triathletes Lion...

Aytu BioScience, Inc.: Aytu BioScience to Present at Upcoming March Investor Conferences ENGLEWOOD, CO / ACCESSWIRE / February 24, 2021 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced that Josh Disbrow, Chairman and Chief Executive Officer will present at three upcoming investor conferences in March: Cowen 41 st Annual Healthcare Conference: A live virtual presentation wil...

(2) Live Conference Call and Webcast at 4:30 PM ET ENGLEWOOD, CO / ACCESSWIRE / February 4, 2021 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today that the Company will present its operational results for the fiscal second quarter ended December 31, 2020 on February 11, 2021, at 4:30 p.m. ET. The Company will review accomplishments from the quarter and provid...

(2) ENGLEWOOD, CO / ACCESSWIRE / December 15, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), ("Aytu" or "the Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today the closing of its previously announced underwritten public offering of 4,791,667 shares of common stock of the Company, which includes the full exercise of the underwriters option to purchase an additional 625,000 shares of common stock, at a price...

Merger accelerates transformation to profitability, with estimated annualized cost synergies of $15M beginning FY 2022 Aytu adds Neos' established,